JAGX - jaguar.health Full Takeover Company Value

Jaguar Health, Inc. (JAGX) develops plant-based treatments for chemotherapy-induced diarrhea, ensuring stable demand. This daily price action on GURU.Markets shows the enterprise value at 13.78, while ownership of unique formulas enables the scaling of global sales with high profitability. However, limited market reach and regulatory costs are constraining the overall growth of business efficiency.

jaguar.health (JAGX) - Total Company Value from 11/23/2025 to 10/31/2026

Jaguar Health, Inc. (JAGX) - metric breakdowns and financial figures

- market price and analyst price targets:

Stock Price Jaguar Health Inc|JAGX - Analyst Consensus Forecast

- market capitalization statistics:

Market Capitalization Jaguar Health|JAGX - Real Price to Acquire Entire Company

- company book value details:

Equity per Share Jaguar Health|JAGX - Company Book Value|Market Capitalization to Net Assets jaguar.health|JAGX - Company Total Assets

- company total debt and liquidity indicators:

- earnings and valuation multiples indicators:

JAGX - Net Income

Analysis of all company metrics:Jaguar Health Inc

Enterprise value reflects the actual cost of acquiring a business, combining market capitalization and net debt to assess the impact of debt load on asset value. For Jaguar Health, Inc. (JAGX), which develops GI therapies for cancer patients, the trend of market capitalization plus net debt helps determine whether an investor is overpaying for access to the massive supportive care drug market.

Competitors of Jaguar Health, Inc. (JAGX)